Liquidia's Customers Performance

Name: Liquidia Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

LQDA

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


LQDA's Source of Revenues		During the corresponding time, Liquidia Corporation recorded a revenue increase by 1842.73 % year on year, sequentially revenue grew by 29.21 %. While revenue at the Liquidia Corporation's corporate clients • List of LQDA Customers

for the same period Liquidia Corporation recorded revenue increase by 1842.73 % year on year, sequentially revenue grew by 29.21 %.

• List of LQDA Customers

Liquidia's Business Units


Product	174.9 %	of total Revenue
Service	2.49 %	of total Revenue
Single reportable segment	177.39 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Liquidia's Comment on Sales, Marketing and Customers

News about Liquidia Corporation Contracts

Liquidia Corporation’s YUTREPIA (Treprostinil) Inhalation Powder Receives FDA Acceptance for New Drug Application R...

Liquidia Corporation has recently announced a significant milestone in its journey to bring YUTREPIA (treprostinil) inhalation powder to market. The U.S. Food and Drug Administration (FDA) has officially accepted the company s resubmission of its New Drug Application (NDA) for this innovative treatment. This development marks a crucial step in the potential commercialization of a medication aimed at addressing the unmet needs of patients with pulmonary arterial hypertension (PAH).Treprostinil, a known vasodilator, plays a vital role in the management of PAH, a progressive condition characterized by high blood pressure in the pulmonary arteries, which can lead to significant morbidity and mortality. Patients ...

Clearing the Path: Legal and Regulatory Advances Raise Hopes for YUTREPIA's FDA Approval

In a recent breakthrough for Liquidia Corporation, the U.S. District Court for the District of Delaware has set aside an injunction that had previously prevented the U.S. Food and Drug Administration (FDA) from issuing final approval of Liquidia s New Drug Application (NDA) for YUTREPIA (treprostinil) inhalation powder. This development signifies significant progress and opens doors for potential FDA approval, highlighting the potential benefits of YUTREPIA for patients. Background:In August 2022, United Therapeutics (UTHR) filed a lawsuit against Liquidia in the Original Hatch-Waxman Litigation, which resulted in an injunction that hindered FDA approval of YUTREPIA. However, on March 28, Judge Andrews of th...

Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD

Liquidia Corporation, a leading pharmaceutical company, recently shared an update on the development of its extensive clinical pipeline programs aimed at treating pulmonary arterial hypertension (PAH) and pulmonary hypertension connected with interstitial lung disease (PH-ILD).The company s most promising investigational drugs, YUTREPIA (treprostinil) inhalation powder and L606, are making noteworthy progression, representing significant advancements in the treatment landscape for PAH and PH-ILD. These two conditions are rare but life-threatening diseases characterized by high blood pressure in the arteries which supply the lungs. YUTREPIA (treprostinil) is an inhalation powder designed to treat pulmonary ar...

LQDA's Stock Performance relative to it's Customers

LQDA's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Liquidia Corporation	6,957.10	288.07	22.31	216
SUBTOTAL	0.00	0.00	0.00	-

Sources: Liquidia Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Liquidia Corporation’s corporate clients.
For your research, we’ve provided 9 tables on Liquidia Corporation corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.